![James McLean](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James McLean
Voorzitter bij AROA BIOSURGERY LIMITED
Vermogen: 1 M $ op 31-05-2024
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
James Agnew | M | - | 11 jaar | |
Brian Ward | M | - | 16 jaar | |
John Pinion | M | 58 | 9 jaar | |
John Diddams | M | - | 5 jaar | |
Catherine Mohr | M | 56 | 2 jaar | |
Philip McCaw | M | - |
Mesynthes Nominee Ltd.
| 16 jaar |
Rod Stanley | M | - | 11 jaar | |
Barnaby May | M | - | 16 jaar | |
Patrick Hunt | M | - | 6 jaar | |
Scott Sherriff | M | - | 1 jaar | |
Sarah Tora | F | - | - | |
Rachel Stuart | F | - | 2 jaar | |
Simon Hinsley | M | - | - | |
Neetha Alex-Kumar | F | - | 3 jaar | |
Frazer Murray | M | - | 4 jaar | |
Brad Adams | M | - | 5 jaar | |
Tim Goodacre | M | - |
Prevar Ltd.
| - |
Tracy Weimar | F | - | - | |
Yasmin Winchester | F | - | 10 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Stephen G. Hall | M | - |
Genesis Research & Development Corp. Ltd.
![]() Genesis Research & Development Corp. Ltd. Financial ConglomeratesFinance Genesis Research & Development Corp. Ltd. operates as a development stage company. Previously, it was a technology investment company that builds a broad therapeutic development platform targeting immune disorders and cancer and a novel single stranded gene silencing technology using the RNAi mechanism. The company was founded by James Douglas Watson in 1994 and is headquartered in Auckland, New Zealand. | - |
Steven Engle | M | 69 | 9 jaar | |
Andrew John Hubert Gearing | M | - |
Genesis Research & Development Corp. Ltd.
![]() Genesis Research & Development Corp. Ltd. Financial ConglomeratesFinance Genesis Research & Development Corp. Ltd. operates as a development stage company. Previously, it was a technology investment company that builds a broad therapeutic development platform targeting immune disorders and cancer and a novel single stranded gene silencing technology using the RNAi mechanism. The company was founded by James Douglas Watson in 1994 and is headquartered in Auckland, New Zealand. | 6 jaar |
Stewart Washer | M | 54 |
Genesis Research & Development Corp. Ltd.
![]() Genesis Research & Development Corp. Ltd. Financial ConglomeratesFinance Genesis Research & Development Corp. Ltd. operates as a development stage company. Previously, it was a technology investment company that builds a broad therapeutic development platform targeting immune disorders and cancer and a novel single stranded gene silencing technology using the RNAi mechanism. The company was founded by James Douglas Watson in 1994 and is headquartered in Auckland, New Zealand. | 6 jaar |
Douglas Williams | M | 66 |
Genesis Research & Development Corp. Ltd.
![]() Genesis Research & Development Corp. Ltd. Financial ConglomeratesFinance Genesis Research & Development Corp. Ltd. operates as a development stage company. Previously, it was a technology investment company that builds a broad therapeutic development platform targeting immune disorders and cancer and a novel single stranded gene silencing technology using the RNAi mechanism. The company was founded by James Douglas Watson in 1994 and is headquartered in Auckland, New Zealand. | 1 jaar |
Joachim von Roy | M | 79 |
Genesis Research & Development Corp. Ltd.
![]() Genesis Research & Development Corp. Ltd. Financial ConglomeratesFinance Genesis Research & Development Corp. Ltd. operates as a development stage company. Previously, it was a technology investment company that builds a broad therapeutic development platform targeting immune disorders and cancer and a novel single stranded gene silencing technology using the RNAi mechanism. The company was founded by James Douglas Watson in 1994 and is headquartered in Auckland, New Zealand. | - |
Nivedita Findlay | F | - |
Genesis Research & Development Corp. Ltd.
![]() Genesis Research & Development Corp. Ltd. Financial ConglomeratesFinance Genesis Research & Development Corp. Ltd. operates as a development stage company. Previously, it was a technology investment company that builds a broad therapeutic development platform targeting immune disorders and cancer and a novel single stranded gene silencing technology using the RNAi mechanism. The company was founded by James Douglas Watson in 1994 and is headquartered in Auckland, New Zealand. | 6 jaar |
Ewe Poh Lim | F | - |
Genesis Research & Development Corp. Ltd.
![]() Genesis Research & Development Corp. Ltd. Financial ConglomeratesFinance Genesis Research & Development Corp. Ltd. operates as a development stage company. Previously, it was a technology investment company that builds a broad therapeutic development platform targeting immune disorders and cancer and a novel single stranded gene silencing technology using the RNAi mechanism. The company was founded by James Douglas Watson in 1994 and is headquartered in Auckland, New Zealand. | - |
Simone von Fircks | F | - | - | |
Caroline Quay | F | - | 6 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Nieuw-Zeeland | 29 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- James McLean
- Persoonlijk netwerk